Literature DB >> 24126700

Connective tissue diseases: Integrins crucial for the onset of fibrosis in systemic sclerosis--a new therapeutic target?

Katrina Ray.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24126700     DOI： 10.1038/nrrheum.2013.144

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN： 1759-4790            Impact factor:   20.543


× No keyword cloud information.
  1 in total

1.  Integrin-modulating therapy prevents fibrosis and autoimmunity in mouse models of scleroderma.

Authors:  Elizabeth E Gerber; Elena M Gallo; Stefani C Fontana; Elaine C Davis; Fredrick M Wigley; David L Huso; Harry C Dietz
Journal:  Nature       Date:  2013-10-09       Impact factor: 49.962
  1 in total
  2 in total

Review 1.  Mesenchymal stem cells in fibrotic diseases-the two sides of the same coin.

Authors:  Lei Qin; Nian Liu; Chao-le-Meng Bao; Da-Zhi Yang; Gui-Xing Ma; Wei-Hong Yi; Guo-Zhi Xiao; Hui-Ling Cao
Journal:  Acta Pharmacol Sin       Date:  2022-07-27       Impact factor: 7.169

2.  Downregulation of CFIm25 amplifies dermal fibrosis through alternative polyadenylation.

Authors:  Tingting Weng; Jingjing Huang; Eric J Wagner; Junsuk Ko; Minghua Wu; Nancy E Wareing; Yu Xiang; Ning-Yuan Chen; Ping Ji; Jose G Molina; Kelly A Volcik; Leng Han; Maureen D Mayes; Michael R Blackburn; Shervin Assassi
Journal:  J Exp Med       Date:  2020-02-03       Impact factor: 14.307
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.